ISSN 1016-5169 | E-ISSN 1308-4488
Archives of the Turkish Society of Cardiology
Ranolazin: mechanism of antianginal effects [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2016; 44(3): 8-12 | DOI: 10.5543/tkda.2016.72626

Ranolazin: mechanism of antianginal effects

Murat Özdemir
Gazi Üniversitesi Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Ankara

Ranolazin is indicated for the control of angina in patients with chronic stable coronary artery disease. Born as a “metabolic modulator”, ranolazine is now considered to be a “late sodium current blocker”. This review tries to summarize the mechanism of antianginal effects of ranolazine.

How to cite this article
Murat Özdemir. Ranolazin: mechanism of antianginal effects. Turk Kardiyol Dern Ars. 2016; 44(3): 8-12

Corresponding Author: Murat Özdemir, Türkiye
Manuscript Language: Turkish
TOOLS Full Text PDF Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Send email to author Similar articles PubMed Google Scholar


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper: 0.22
SCImago Journal Rank: 0.348

Quick Search



  1. Home
  2. Abstrating and Indexing
  3. Copyright
  1. Aim and Scope
  2. Editorial Board
  3. Instructions for Authors
  1. ICMJE Recommendations
  2. Contact

Copyright © 2024 Archives of the Turkish Society of Cardiology



Kare Publishing is a subsidiary of Kare Media. 
LookUs  &   Online Makale